Dimethyllysergamide
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Psychonaut25 (talk | contribs) at 11:37, 25 October 2013. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 11:37, 25 October 2013 by Psychonaut25 (talk | contribs)
Clinical data | |
---|---|
Other names | DAM-57, Lysergic acid dimethylamide |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | hepatic |
Excretion | renal |
Identifiers | |
| |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H21N3O |
Molar mass | 295.39 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
N,N-Dimethyllysergamide or N,N-dimethyl-D-lysergamide (DAM-57) is a derivative of ergine. There has been a single report of observing N,N-dimethyl-D-lysergamide in the illicit drug market.[1] This compound did induce autonomic disturbances at oral levels of some ten times the dosage required for LSD, presumably in the high hundreds of micrograms. There is some disagreement as to whether there were psychic changes observed.[2]
References
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Drugs with non-standard legal status
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugboxes which contain changes to watched fields
- All stub articles